Heart failure & cardiomyopathies

Genetically Predicted Androgenic Profiles and Adverse Cardiac Markers: A Sex-Specific Mendelian Randomization Study

ESC Heart FailPublished Mendelian randomisation study

Authors' conclusion

This study supports a causal effect of pro-androgenic sex hormone profiles in females on adverse markers of left ventricular structure and function typically associated with HF with preserved ejection fraction and with HF. There was weaker evidence of association in males.

Study context

Population
UK Biobank participants (genome-wide association study (GWAS) n = 425,097); UK Biobank Imaging Study (11,528 females, 14,356 males); external heart failure (HF) cohort (47,309 cases, 930,014 controls)11,528 female and 14,356 male imaging participants
Comparison
Genetically predicted androgenic sex hormone profiles (sex hormone-binding globulin (SHBG), total testosterone, bioavailable testosterone) and cardiac structure/function and HF
Methodological detailssex-specific, inverse-variance weighted Mendelian randomization (MR) (primary analysis)
  • Sex-specific
  • Inverse-variance weighted MR (primary analysis)

Main finding

As reported in the abstract

Odds ratio (CI)P value
Bioavailable testosterone (females)HF; external validation, sex-adjusted GWAS data
1.10(1.01–1.19)
P = 0.026
Bioavailable testosterone (females) · LVEDV
β per nmol/L −0.11 (CI −0.19 to −0.03); P = 0.006
Bioavailable testosterone (females) · LVESV
β −0.09 (CI −0.17 to −0.01); P = 0.022
Bioavailable testosterone (females) · LV stroke volume
β −0.11 (CI −0.18 to −0.03); P = 0.005
Bioavailable testosterone (females) · cardiac output
β −0.08 (CI −0.16 to 0.00); P = 0.046
Bioavailable testosterone (females) · cardiac index
β −0.08 (CI −0.16 to −0.01); P = 0.034
Total testosterone (males) · LVESV
β −0.07 (CI −0.12 to −0.02); P = 0.007
Bioavailable testosterone (males) · left ventricular ejection fraction (LVEF)
β −0.11 (CI −0.18 to −0.04); P = 0.003

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Genetically Predicted Androgenic Profiles and Adverse Cardiac Markers: A Sex-Specific Mendelian Randomization Study. ESC Heart Fail. Published 22 September 2023. doi:10.1002/ehf2.14527

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.